Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
DENOSUMAB INJ (PROLIA) 60MG/1ML SYRN (OTHER 6001733) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved July 4, 2026 , from http://ppman.hank.ai/transparency/procedure/6001733/by-state?code_type=OTHER
“DENOSUMAB INJ (PROLIA) 60MG/1ML SYRN (OTHER 6001733) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/6001733/by-state?code_type=OTHER. Accessed
July 4, 2026 .
“DENOSUMAB INJ (PROLIA) 60MG/1ML SYRN (OTHER 6001733) by State,” HANK Price Transparency ,
accessed July 4, 2026 ,
http://ppman.hank.ai/transparency/procedure/6001733/by-state?code_type=OTHER.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
OTHER · across United States
6001733 — Denosumab Inj (prolia) 60mg/1ml Syrn
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$1,907
National median
$1,221 – $2,065
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 6001733 (OTHER), with interquartile range
State Median p25 p75
TX $1,907 $1,221 $2,065